Patents by Inventor Keiichi Fukuda

Keiichi Fukuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150366918
    Abstract: The object of the present invention is to improve the post-transplantation engraftment rate of cardiomyocytes that have been purified to such an extent that they are free from non-cardiomyocytes and any components derived from other species. To solve this problem, the present inventors studied the possibility of constructing cell masses from the purified cardiomyocytes. As a result, they revealed that the stated problem could be solved by providing a method of preparing cell masses of cardiomyocytes derived from pluripotent stem cells, characterized in that cell masses of aggregated cells containing cardiomyocytes that had been differentiated and induced from pluripotent stern cells were dispersed to single cells to thereby obtain purified cardiomyocytes, which were then cultured in a culture medium under serum-free conditions so that they were reaggregated.
    Type: Application
    Filed: July 14, 2015
    Publication date: December 24, 2015
    Applicants: DAIICHI SANKYO COMPANY, LIMITED, KEIO UNIVERSITY
    Inventors: Fumiyuki HATTORI, Keiichi FUKUDA
  • Patent number: 9115342
    Abstract: An object of the present invention is to develop a method for purify cardiomyocytes at a high degree of purification and at a high yield from a cell mixture comprising cardiomyocytes derived from fetuses and stem cells using various features which have not been previously expected to be used for purification of cardiomyocytes or which are newly found, wherein said method is carried out without undergoing any genetic modification or without adding any special proteins or biologically active agents.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: August 25, 2015
    Assignees: DAIICHI SANKYO COMPANY, KEIO UNIVERSITY
    Inventors: Fumiyuki Hattori, Keiichi Fukuda
  • Patent number: 9109205
    Abstract: The object of the present invention is to improve the post-transplantation engraftment rate of cardiomyocytes that have been purified to such an extent that they are free from non-cardiomyocytes and any components derived from other species. To solve this problem, the present inventors studied the possibility of constructing cell masses from the purified cardiomyocytes. As a result, they revealed that the stated problem could be solved by providing a method of preparing cell masses of cardiomyocytes derived from pluripotent stem cells, characterized in that cell masses of aggregated cells containing cardiomyocytes that had been differentiated and induced from pluripotent stem cells were dispersed to single cells to thereby obtain purified cardiomyocytes, which were then cultured in a culture medium under serum-free conditions so that they were reaggregated.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: August 18, 2015
    Assignees: DAIICHI SANKYO COMPANY, LIMITED, KEIO UNIVERSITY
    Inventors: Fumiyuki Hattori, Keiichi Fukuda
  • Patent number: 9096720
    Abstract: Disclosed are a method for producing a polyaspartic acid precursor polymer by polymerization using at least one kind selected from a product obtained from maleic anhydride and ammonia and, maleamic acid as a monomer, wherein at least part of carboxyl groups in the monomers are a tertiary amine salt; and an industrially inexpensive and simple method for producing a polyaspartic acid salt by treating the polyaspartic acid precursor polymer obtained by this method with a basic aqueous solution.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: August 4, 2015
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Kouki Fukumura, Hironori Kuboi, Keiichi Fukuda
  • Patent number: 8841250
    Abstract: The present invention relates to muscle repair promoters for local application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly when they are administered intramuscularly.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: September 23, 2014
    Inventor: Keiichi Fukuda
  • Patent number: 8774241
    Abstract: To constitute an optical module comprising a mount and a board that supports the mount, wherein a solid-state laser device that oscillates fundamental laser light, a pump light source that pumps the solid-state laser device, and a wavelength converting device that converts a wavelength of the fundamental laser light oscillated by the solid-state laser device are mounted on the mount, the mount is divided into three blocks, that is, a first block on which a laser medium is mounted, a second block on which the pump light source is mounted, and a third block on which the wavelength converting device is mounted. A side surface or a bottom surface of only the second block is fixed to the board, the first block is fixed to the other side surface of the second block, and the third block is fixed to a side surface of the first block.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: July 8, 2014
    Assignee: Mitsubishi Electric Corporation
    Inventors: Akira Nakamura, Masamitsu Okamura, Keiichi Fukuda, Chise Nanba, Kazutaka Ikeda
  • Patent number: 8735152
    Abstract: The present invention has as its object developing a method that does not involve genomic modification and which yet is capable of inducing cell death in pluripotent stem cells such as embryonic stem cells and induced pluripotent stem cells, as well as in differentiated cells other than cardiomyocytes derived from pluripotent stem cells, but not in cardiomyocytes. It has been revealed that by establishing a method capable of inducing cell death in cells other than cardiomyocytes in a very efficient manner by adding a substance having no recognized inherent toxicity or cell death inducing action to the culture conditions for pluripotent stem cells and non-cardiomyocytes, the stated problem can be solved without relying upon genomic modification.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: May 27, 2014
    Assignees: Daiichi Sankyo Company, Limited, Keio University
    Inventors: Fumiyuki Hattori, Keiichi Fukuda
  • Patent number: 8695211
    Abstract: In a push-button switch manufacturing method, a key-top end of a pressing element is inserted into a lower-mold recess. A reinforcing plate is placed in the lower mold so that the pressing element extends through a plate through hole of the reinforcing plate. An upper mold and the lower mold are moved toward each other so as to insert the other end of the pressing element into an upper-mold recess for the pressing element, which is provided in a lower surface of the upper mold. A liquid silicone rubber, which contains a component that does not adhere to the upper and lower molds but adheres to the pressing element, is introduced into a cavity, the upper and lower molds are opened to remove a molded product in which an intermediate portion in an axial direction of the pressing element is supported in the plate through hole by the silicone rubber.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: April 15, 2014
    Assignee: Shin-Etsu Polymer Co., Ltd.
    Inventors: Shunta Hyuga, Norio Suzuki, Keiichi Fukuda, Haruaki Miyamura
  • Patent number: 8623649
    Abstract: The invention relates to methods of selecting a cardiomyocyte from a cell population derived from a whole heart or a differentiated cell population derived from a stem cell without genetic alteration. Specifically, the invention relates to a method of selecting a cardiomyocyte from a cardiomyocyte-containing cell mixture without genetic alteration of a cardiomyocyte, on the basis of a relative content of cellular mitochondria and/or a relative mitochondrial transmembrane potential of the cell. The invention also relates to methods of enriching a cardiomyocyte from a cardiomyocyte-containing cell mixture without genetic alteration of a cardiomyocyte, producing a cardiomyocyte without genetic alteration of a cardiomyocyte, and evaluating the ratio of a cardiomyocyte in a cardiomyocyte-containing cell mixture.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: January 7, 2014
    Assignees: Daiichi Sankyo Company, Limited, Keio University
    Inventors: Fumiyuki Hattori, Keiichi Fukuda
  • Publication number: 20130302271
    Abstract: The present invention relates to muscle repair promoters for local application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly when they are administered intramuscularly.
    Type: Application
    Filed: July 15, 2013
    Publication date: November 14, 2013
    Inventor: Keiichi Fukuda
  • Publication number: 20130302272
    Abstract: The present invention provides therapeutic agents for diseases associated with skeletal muscle degeneration comprising a granulocyte colony-stimulating factor (G-CSF) as an active ingredient. The therapeutic agents of the present invention are especially effective as therapeutic agents for muscular dystrophy.
    Type: Application
    Filed: November 17, 2011
    Publication date: November 14, 2013
    Inventors: Keiichi Fukuda, Shinsuke Yuasa
  • Patent number: 8553738
    Abstract: In a laser light source device having an optical element and a plurality of heat sinks on which the optical element is joined directly or through a sub mount, and obtained by joining the heat sinks to each other by means of a joining material such that optical elements are optically directly joined to each other, the laser light source device includes a groove portion extending in a direction substantially orthogonal to an optical axis of light in the laser light source device on any one of a joining surface of the optical element or the sub mount to join with the heat sink and a joining surface of the heat sink to join with the optical element or the sub mount.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: October 8, 2013
    Assignee: Mitsubishi Electric Corporation
    Inventors: Shinichi Oe, Motoaki Tamaya, Akira Nakamura, Keiichi Fukuda
  • Publication number: 20130258505
    Abstract: A method of manufacturing an optical apparatus having an optical element, a holding member, and a base member includes preparing the holding member and fixing the optical element to the first member. The method further includes fixing a second member of the holding member to the base member and plastically deforming a first member of the holding member and the second member to adjust the position of the optical element.
    Type: Application
    Filed: February 27, 2013
    Publication date: October 3, 2013
    Inventors: Nobuyuki YASUI, Takehiko Nakahara, Masaya Shimono, Keiichi Fukuda, Keita Mochizuki, Hiroshi Aruga, Kenichi Uto, Tadashi Murao, Hidekazu Kodera
  • Publication number: 20130260228
    Abstract: The lithium-ion secondary battery includes a positive electrode containing an active material made of a compound including lithium and a transition metal; an electrolyte containing 5 to 30 ppm of hydrofluoric acid; and a negative electrode containing 1 to 100 ppm of vanadium.
    Type: Application
    Filed: March 18, 2013
    Publication date: October 3, 2013
    Applicant: TDK CORPORATION
    Inventors: Atsushi SANO, Keitaro OTSUKI, Masahiro OISHI, Keiichi FUKUDA
  • Publication number: 20130260226
    Abstract: A nonaqueous electrolyte for a lithium-ion secondary battery containing 0.1 ppm to 20 ppm of vanadium in terms of vanadium ions, and containing cyclic carbonate and chain carbonate is used.
    Type: Application
    Filed: March 18, 2013
    Publication date: October 3, 2013
    Applicant: TDK CORPORATION
    Inventors: Atsushi SANO, Keitaro OTSUKI, Keiichi FUKUDA
  • Publication number: 20130189786
    Abstract: An object of the present invention is to provide methods for producing iPS cells with low invasivity and high efficiency. The iPS cells can be produced with high efficiency using a method comprising the steps of culturing mononuclear cells derived from peripheral blood for 3 to 14 days in the presence of anti-CD3 antibody, and subjecting the cultured mononuclear cells to dedifferentiation.
    Type: Application
    Filed: April 15, 2011
    Publication date: July 25, 2013
    Applicants: Dnavec Corporation, Keio University
    Inventors: Keiichi Fukuda, Shinsuke Yuasa, Tomohisa Seki, Mamoru Hasegawa
  • Publication number: 20130062338
    Abstract: The present invention relates to a jacket heater having a heating element built therein, the jacket heater containing: the heating element having a watt density of 0.15 W/cm2 or more, a metal foil disposed adjacently to the heating element, and a surrounding body which surrounds the heating element and the metal foil.
    Type: Application
    Filed: April 6, 2011
    Publication date: March 14, 2013
    Inventors: Kenji Iida, Daisaku Seki, Akira Sasaki, Yoshiyuki Motoyoshi, Mitsushi Wadasako, Keiichi Fukuda
  • Publication number: 20120309909
    Abstract: Disclosed are a method for producing a polyaspartic acid precursor polymer by polymerization using at least one kind selected from a product obtained from maleic anhydride and ammonia and, maleamic acid as a monomer, wherein at least part of carboxyl groups in the monomers are a tertiary amine salt; and an industrially inexpensive and simple method for producing a polyaspartic acid salt by treating the polyaspartic acid precursor polymer obtained by this method with a basic aqueous solution.
    Type: Application
    Filed: February 10, 2011
    Publication date: December 6, 2012
    Inventors: Kouki Fukumura, Hironori Kuboi, Keiichi Fukuda
  • Publication number: 20120227251
    Abstract: In a manufacturing method of a push-button switch, a key-top end of a pressing element 25 is inserted into a lower-mold recess for the pressing element, which is provided in a surface of a lower mold. A reinforcing plate 28 is placed in the lower mold so that the pressing element 25 extends through a plate through hole of the reinforcing plate 28. An upper mold and the lower mold are moved toward each other so as to insert the other end of the pressing element 25 into an upper-mold recess for the pressing element, which is provided in a lower surface of the upper mold. A liquid silicone rubber 27, which contains a component that does not adhere to the upper and lower molds but adheres to the pressing element 25, is introduced into a cavity.
    Type: Application
    Filed: July 21, 2011
    Publication date: September 13, 2012
    Applicant: Shin-Etsu Polymer Co., Ltd.
    Inventors: Shunta Hyuga, Norio Suzuki, Keiichi Fukuda, Haruaki Miyamura
  • Patent number: 8265111
    Abstract: When a laser light source module includes a heat sink in which a solid laser element, an excitation light source, and a wavelength conversion element are arranged and a stem that supports the heat sink, wherein the heat sink is separated into three blocks, namely a first block including a laser oscillating unit for the solid laser element is arranged, a second block including a semiconductor laser element that emits excitation light for the laser oscillating unit and a first temperature sensor are arranged and on a specific surface of which the first heater is arranged, and a third block including the wavelength conversion element that converts the wavelength of the fundamental laser beam and a second temperature sensor are arranged and on a specific surface of which a second heater is arranged, enabling thus downsizing of the module and improvement of the positioning accuracy of the elements.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: September 11, 2012
    Assignee: Mitsubishi Electric Corporation
    Inventors: Motoaki Tamaya, Chise Nanba, Akira Nakamura, Keiichi Fukuda, Koji Funaoka, Manabu Kawakami, Masamitsu Okamura